Patients with invasive lobular carcinoma could benefit from additional adjuvant thera

[News]

New results presented at the 12th European Breast Cancer Conference show that a test, which looks at the activity of 70 genes in breast cancer tissue, is possible to use in the clinic to identify patients with invasive lobular carcinoma (ILC) that is at high risk of recurring and progressing.

More... (https://www.news-medical.net/news/20201001/Patients-with-invasive-lobular-carcinoma-could-benefit-from-additional-adjuvant-therapy.aspx)